P. Butera

433 total citations
10 papers, 316 citations indexed

About

P. Butera is a scholar working on Pulmonary and Respiratory Medicine, Anesthesiology and Pain Medicine and Emergency Medical Services. According to data from OpenAlex, P. Butera has authored 10 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Anesthesiology and Pain Medicine and 3 papers in Emergency Medical Services. Recurrent topics in P. Butera's work include Respiratory and Cough-Related Research (6 papers), Pain Management and Opioid Use (3 papers) and Pediatric health and respiratory diseases (3 papers). P. Butera is often cited by papers focused on Respiratory and Cough-Related Research (6 papers), Pain Management and Opioid Use (3 papers) and Pediatric health and respiratory diseases (3 papers). P. Butera collaborates with scholars based in United States, United Kingdom and Switzerland. P. Butera's co-authors include N. Friedmann, Lindsay H. Burns, Nancy Wu, Lauren V. Moran, Lynn R. Webster, Michael M. Kitt, Richard Craven, Vishala Chindalore, Anthony Ford and John A. Smith and has published in prestigious journals such as European Respiratory Journal, Thorax and Journal of Pain.

In The Last Decade

P. Butera

10 papers receiving 299 citations

Peers

Countries citing papers authored by P. Butera

Since Specialization

Citations

This map shows the geographic impact of P. Butera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Butera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Butera more than expected).

Fields of papers citing papers by P. Butera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Butera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Butera. The network helps show where P. Butera may publish in the future.

Co-authorship network of co-authors of P. Butera

This figure shows the co-authorship network connecting the top 25 collaborators of P. Butera. A scholar is included among the top collaborators of P. Butera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Butera. P. Butera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Single‐ and Multiple‐Dose Pharmacokinetics of Gefapixant (MK‐7264), a P2X3 Receptor Antagonist, in Healthy Adults 2024 ·The Journal of Clinical Pharmacology ·Jesse C. Nussbaum, Azher Hussain, P. Butera, Anthony Ford, Michael M. Kitt, Edward A. O’Neill, Steven A. Smith, Gabriel Vargas, Terry O’Reilly, Chris Wynne, S. Aubrey Stoch, Marian Iwamoto	4
2	A Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of 3 Weeks of Orally Administered Gefapixant in Healthy Younger and Older Adults 2022 ·Lung ·Jesse C. Nussbaum, Azher Hussain, Anthony Ford, P. Butera, Michael M. Kitt, Stephen M. Smith, Aubrey Stoch, Marian Iwamoto	1
3	Gefapixant in two randomised dose-escalation studies in chronic cough 2020 ·European Respiratory Journal ·John A. Smith, Michael M. Kitt, P. Butera, Steven A. Smith, Yuping Li, Zhi Jin Xu, Kimberley Holt, (unknown), Mandel Sher, Anthony Ford	97
4	The Efficacy of Bradanicline in Refractory Chronic Cough 2020 ·Yoshihiro Kanemitsu, John A. Smith, P. Butera, Brendan J. Canning, Peter V. Dicpinigaitis, Vivek Iyer, Michael M. Kitt	9
5	S27 The effect of P2X3 antagonism (AF–219) on experimentally evoked cough in healthy volunteers and chronic cough patients 2016 ·Thorax ·JA Smith, Michael M. Kitt, P. Butera, Anthony Ford	8
6	LATE-BREAKING ABSTRACT: Tackling the burden of chronic cough: A dose escalation study of AF-219 2016 ·John A. Smith, Michael M. Kitt, Mandel Sher, P. Butera, Anthony Ford	2
7	A Phase 2 Study in Women with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) of the Novel P2X3 Antagonist AF-219 2015 ·Neurourology and Urodynamics ·Robert Moldwin, Michael M. Kitt, Jeffrey Mangel, (unknown), (unknown), P. Butera, Anthony Ford	6
8	Oxytrex Minimizes Physical Dependence While Providing Effective Analgesia: A Randomized Controlled Trial in Low Back Pain 2006 ·Journal of Pain ·Lynn R. Webster, P. Butera, Lauren V. Moran, Nancy Wu, Lindsay H. Burns, N. Friedmann	99
9	(755) 2006 ·Journal of Pain ·(unknown), P. Butera, David Gilmore, Landhing M. Moran, N. Friedmann	5
10	Adding Ultralow-Dose Naltrexone to Oxycodone Enhances and Prolongs Analgesia: A Randomized, Controlled Trial of Oxytrex 2005 ·Journal of Pain ·Vishala Chindalore, Richard Craven, (unknown), P. Butera, Lindsay H. Burns, N. Friedmann	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact